Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Pain Symptom Manage ; 7(7): 400-5, 1992 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-1484193

RESUMO

Administration of morphine by the oral route is not possible in cancer patients who are unable to swallow or are intolerant of oral morphine. Thus, there is a need for reliable alternate routes of drug administration. We compared the bioavailability of two prototype 30-mg morphine sulfate controlled-release suppository formulations (high and low viscosity) with 30-mg oral controlled-release morphine sulfate tablets in a 14-subject single-dose randomized, three-way crossover study. Venous blood samples were obtained immediately prior to and for 24 hr following each dose. Morphine concentrations were determined by radioimmunoassay. Compared with oral controlled-release morphine, the high- and low-viscosity suppository formulations had significantly greater bioavailability (AUC0-24 72.7 +/- 13.2 for the oral preparation versus 98.6 +/- 35.7 and 105.8 +/- 37.3 ng.hr/mL for the suppositories, respectively, P < 0.05), later peak concentration (tmax 2.3 +/- 0.8 versus 3.1 +/- 2.3 and 5.0 +/- 1.5 hr, respectively, P < 0.05), and longer half-value duration (4.3 +/- 1.6 versus 10.4 +/- 5.5 and 9.5 +/- 4.3 hr, respectively, P < 0.05). Peak concentration for the high-viscosity suppository formulation (Cmax 7.75 +/- 2.66 ng/mL) was significantly lower than the low-viscosity suppository (Cmax 9.23 +/- 2.85 ng/mL) and the oral tablet (Cmax 10.4 +/- 2.78 ng/mL) formulations (P < 0.05). The increased bioavailability observed with the two controlled-release suppositories may be the result of partial avoidance of hepatic biotransformation with rectal administration.


Assuntos
Morfina/administração & dosagem , Administração Retal , Adulto , Disponibilidade Biológica , Preparações de Ação Retardada , Humanos , Masculino , Morfina/sangue , Morfina/farmacocinética
2.
Carbohydr Res ; 55: 11-9, 1977 May.
Artigo em Inglês | MEDLINE | ID: mdl-861971

RESUMO

A polysaccharide, isolated from rapeseed hulls by extraction with aqueous sodium hydroxide-sodium tetraborate, contained residues of L-arabinose, L-fucose, D-xylose, D-galactose, and D-glucose in the proportions of 2:8:25:13:52. Acetolysis furnished cellobiose, 6-O-alpha-D-xylopyranosyl-D-glucose, and 2-O-beta-D-galactopyranosyl D-xylose. The cleavage products from the methylated polysaccharide were examined by g.l.c. of the methyl glycosides and g.l.c.-mass spectrometry of the partially methylated, alditol acetates. The results show that the polysaccharide is a member of the xyloglucan group in which additional fucose and galactose residues terminate some of the side-chains. For comparative purposes, aspects of the structures of xyloglucans from nasturtium seeds and suspension-cultured sycamore cells have been re-examined.


Assuntos
Polissacarídeos/análise , Sementes/análise , Fucose/análise , Galactosídeos/análise , Polissacarídeos/isolamento & purificação
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...